Outpatient total body irradiation for pediatric patients undergoing stem cell transplantation.
We have retrospectively reviewed the ability to safely deliver total body irradiation (TBI) in the outpatient setting in 10 pediatric patients undergoing stem cell transplantation. Patients had a median age of 14 years (range 9-17 years) with diagnoses that included ALL in second remission, AML in second remission, myelodysplastic syndrome, Ewing's sarcoma, and rhabdomyosarcoma. Patients received a total of 1375 cGy or 1440 cGy given in a hyperfractionated schedule (11 or 12 fractions) over a 4-day period. All children were seen in the outpatient clinic daily during TBI and all were housed within a 20 mile radius of our institution during this period. Eight patients achieved good control of nausea and emesis with ondansetron alone while two patients required ondansetron and diphenhydramine. Nine patients received some form of intravenous hydration during this period (hyperalimentation, fluid boluses in clinic, or night-time intravenous fluids). One patient maintained good hydration with oral intake alone. Only one child required admission during this period for persistent nausea and vomiting despite antiemetics and intravenous fluids. A cost approximation suggests that TBI delivered in the outpatient setting resulted in a saving of approximately $2400 per patient. We conclude that TBI administered to children and adolescents in the outpatient setting can be a safe and cost-effective practice.
Dagher
R
R
Stem Cell Transplantation Program, Riley Hospital for Children, Indiana University School of Medicine, Indianapolis 46202-5225, USA.
Robertson
K A
KA
Lucas
K G
KG
Emanuel
D
D
Smith
F O
FO
D000293:Adolescent; D002648:Child; D017048:Health Care Costs; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D010045:Outpatients; D012189:Retrospective Studies; D014916:Whole-Body Irradiation